The basal ganglia are subcortical nuclei that control voluntary actions, and they are affected by a number of debilitating neurological disorders [1] [2] [3] [4] . The prevailing model of basal ganglia function proposes that two orthogonal projection circuits originating from distinct populations of spiny projection neurons (SPNs) in the striatum 5,6 -the so-called direct and indirect pathways-have opposing effects on movement: activity of direct-pathway SPNs is thought to facilitate movement, whereas activity of indirectpathway SPNs is presumed to inhibit movement 1,2 . This model has been difficult to test owing to the lack of methods to selectively measure the activity of direct-and indirect-pathway SPNs in freely moving animals. Here we develop a novel in vivo method to specifically measure direct-and indirect-pathway SPN activity, using Cre-dependent viral expression of the genetically encoded calcium indicator (GECI) GCaMP3 in the dorsal striatum of D1-Cre (direct-pathway-specific 6,7 ) and A2A-Cre (indirect-pathwayspecific 8,9 ) mice 10 . Using fibre optics and time-correlated singlephoton counting (TCSPC) in mice performing an operant task, we observed transient increases in neural activity in both directand indirect-pathway SPNs when animals initiated actions, but not when they were inactive. Concurrent activation of SPNs from both pathways in one hemisphere preceded the initiation of contraversive movements and predicted the occurrence of specific movements within 500 ms. These observations challenge the classical view of basal ganglia function and may have implications for understanding the origin of motor symptoms in basal ganglia disorders.
The basal ganglia are subcortical nuclei that control voluntary actions, and they are affected by a number of debilitating neurological disorders [1] [2] [3] [4] . The prevailing model of basal ganglia function proposes that two orthogonal projection circuits originating from distinct populations of spiny projection neurons (SPNs) in the striatum 5,6 -the so-called direct and indirect pathways-have opposing effects on movement: activity of direct-pathway SPNs is thought to facilitate movement, whereas activity of indirectpathway SPNs is presumed to inhibit movement 1, 2 . This model has been difficult to test owing to the lack of methods to selectively measure the activity of direct-and indirect-pathway SPNs in freely moving animals. Here we develop a novel in vivo method to specifically measure direct-and indirect-pathway SPN activity, using Cre-dependent viral expression of the genetically encoded calcium indicator (GECI) GCaMP3 in the dorsal striatum of D1-Cre (direct-pathway-specific 6,7 ) and A2A-Cre (indirect-pathwayspecific 8, 9 ) mice 10 . Using fibre optics and time-correlated singlephoton counting (TCSPC) in mice performing an operant task, we observed transient increases in neural activity in both directand indirect-pathway SPNs when animals initiated actions, but not when they were inactive. Concurrent activation of SPNs from both pathways in one hemisphere preceded the initiation of contraversive movements and predicted the occurrence of specific movements within 500 ms. These observations challenge the classical view of basal ganglia function and may have implications for understanding the origin of motor symptoms in basal ganglia disorders.
Excitatory inputs to striatum arise from cortical and thalamic structures, while striatal inhibitory output diverges, with some neurons projecting directly to basal ganglia output nuclei (striatonigral SPNs) and others to intermediate nuclei (striatopallidal SPNs), giving rise to the direct and the indirect pathways that propagate throughout the basal ganglia 6, 7 . Despite advances in our understanding of basal ganglia circuitry, the functional relationship between these two pathways and the generation of actions is still under debate. Although the predominant model proposes an 'opposing' scheme primarily based on the polarity of neural transmission in these two pathways and their final convergence onto basal ganglia output nuclei 2 , more recent models propose coordinated activation of both pathways during action selection. Some propose, for example, that activation of the direct pathway could facilitate output of the desired motor programs but that activation of the indirect pathway would inhibit competing motor programs 3, 4, 11 . Others suggest that coordinated activity of direct and indirect pathway is critical for the appropriate timing and synchrony of basal ganglia circuits during movement 12, 13 .
Disambiguating between these models requires monitoring and comparing the activity of direct-and indirect-pathway SPNs in behaving animals 4, 11 . However, electrophysiological recordings have not been useful for this purpose because there are no obvious electrophysiological parameters to distinguish between direct-and indirect-pathway SPN firing, and antidromic stimulation can be difficult 14 and unreliable considering the crosstalk between axon collaterals of the two pathways 14, 15 . Optogenetic techniques have permitted the identification of specific cell types in vivo through optical stimulation of recorded cells 16 or optical monitoring of the activity of cells of a specific cell type 17 . This latter approach has permitted the measurement of neuralactivity-dependent fluorescence changes from specific types of neurons in behaving animals [17] [18] [19] . However, current in vivo imaging methods are not ideal for exploring the activity of subcortical structures in freely moving animals owing to limitations in the penetration depth (,1 mm) and the general requirement for head restraint during measurement 20 .
To circumvent these issues and achieve optical recording of neural activity from striatum in freely moving animals, we developed an in vivo photometry method using time-correlated single-photon counting (TCSPC)-based fibre optics. The TCSPC system includes a 473-nm picosecond-pulsed laser for excitation, a polychromator to disperse the fluorescent emission, a 16-channel photomultiplier (PMT) array for photon detection and a TCSPC module for singlephoton counting (Fig. 1a) . A fibre-optic probe consisting of a singlemode fibre (used to deliver laser pulses) and a multi-mode fibre (to collect emitted photons) is implanted into the desired structure in mouse brain; in our case the dorsal striatum. Photons collected by the TCSPC system can be plotted as time-resolved spectra ( Fig. 1b ). These plots are used to determine the emission spectrum, the fluorescence lifetime of each spectral component, and the integrated fluorescence intensity ( Fig. 1c, d ). Because the emission spectrum and lifetime of a fluorescent indicator are often different from background autofluorescence, these characteristics can be used to discriminate between these signals. As GCaMP3 is an intensity-based GECI whose lifetime does not change with Ca 21 binding ( Supplementary Fig. 1 ), we used changes in GCaMP3 fluorescence intensity ('fluorescent transients') as a readout of neural activity throughout this study, and lifetime and emission spectra as controls for non-specific fluorescence.
The single-mode and multi-mode fibres were joined at the free ends to form a parallel hybrid fibre probe, which was inserted into the dorsal striatum ( Fig. 1a and Supplementary Fig. 2a, b ), and were light and flexible enough to allow animals to move freely (Supplementary Video 1). The effective detection volume of this hybrid probe is the overlap between the volume excited by the single-mode fibre and the acceptance cone of the multi-mode fibre. In fluorescent brain tissue this volume had a depth of around 500 mm (see Methods and Supplementary Fig. 2c-f ).
To express GCaMP3 selectively in direct-and indirect-pathway SPNs, we injected recombinant adeno-associated virus vectors (AAV2/9) containing a double-floxed inverted open reading frame encoding GCaMP3 (FLEX-GCaMP3 (flip-excision genetic switch)) unilaterally into the left dorsal striatum of D1-Cre and A2A-Cre mice 10 . GCaMP3 was therefore expressed specifically in directpathway SPNs (axons projecting to the two main output nuclei of the basal ganglia: the internal segment of globus pallidus (GPi) and substantia nigra pars reticulata (SNr), Fig. 1e ) in D1-Cre mice 21 or in indirect-pathway SPNs (axons terminating in the external segment of globus pallidus (GPe) (Fig. 1g ), and specific expression in indirectpathway SPNs ( Supplementary Fig. 3 )) in A2A-Cre mice.
In all freely moving D1-Cre and A2A-Cre mice with a distinct GCaMP3 spectrum, we routinely observed transient increases in fluorescence intensity (Fig. 1f, h and Supplementary Fig. 5 ), resembling the locomotor-related transients measured previously with microscopy in motor cortex neurons 18 . Transients were more prominent on spectral channels that detect the peak of the GCaMP3 emission spectrum than on off-peak spectral channels in GCaMP3-expressing mice ( Supplementary Fig. 6 ), and were not seen in wild-type mice (Supplementary Fig. 7 ) or mice that expressed green fluorescent protein (GFP) ( Fig. 1i and Supplementary Fig. 5 ). Thus, transients are unlikely to reflect motion-related artefacts. GCaMP3 fluorescence transients decreased substantially after intrastriatal injection of tetrodotoxin (TTX, 200 nM, 500 nl, Fig. 1k , l and Supplementary Fig. 9 ), supporting the idea that they reflect neuronal activity. Consistent with this, deep isoflurane anaesthesia, which temporarily but markedly diminishes activity in the striatum ( Supplementary Fig. 8 ), completely and reversibly blocked GCaMP3 transients ( Fig. 1j , l) and caused a drop in baseline fluorescence ( Supplementary Fig. 7 ). These effects were occluded by previous TTX administration, indicating that isofluraneinduced loss of transients reflected decreased neural activity (Supplementary Fig. 9 ). 
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To determine the relationship between the GCaMP3 transients and SPN firing patterns, we carried out Ca 21 imaging and cell-attached recordings in acutely cut striatal slices. We evoked action potentials by current injection through the patch pipette or by synaptic stimulation, and measured GCaMP3 fluorescence with a CMOS camera (Supplementary Figs 10 and 11, and Supplementary Videos 2 and 3) and the same TCSPC-based fibre probes that we used in vivo (Supplementary Fig. 12 ). These experiments indicate that GCaMP3 fluorescence transients represent Ca 21 responses to suprathreshold synaptic inputs that elicit bursts of action potentials in SPNs.
To examine the relationship between activity in direct-and indirectpathway SPNs and specific self-paced voluntary actions, we measured GCaMP3 fluorescence while mice performed a lever-pressing operant task. We used a two-lever free-choice task in which mice were rewarded after making ten lever presses, regardless of left-or rightlever pressing. GCaMP3 fluorescence showed transient time-locked increases during the initiation of the session (chamber illumination and lever extension), with a similar temporal profile in both direct and indirect pathways in all animals tested ( Fig. 2a-d) ; this is consistent with previous studies showing that SPNs respond to visual and auditory stimuli 22 . This sensory stimulus-evoked response was not seen in D2-GFP control mice ( Fig. 2e ).
We also observed transient increases in GCaMP3 fluorescence during the performance of different actions ( Fig. 2a, b ). During a typical operant session, the animals' behaviour was organized into bouts of lever pressing and magazine checking (operationally labelled here as active states) separated by quiet intervals when the mice were not executing operant actions (inactive states) ( Fig. 3a, b ). If the direct and indirect pathways exert opposing effects on movement, as proposed in the classical model, a higher frequency of transients in directpathway SPNs during 'active' states and higher transient frequency in indirect-pathway SPNs during inactive states should be observed. However, both direct-and indirect-pathway SPNs were more active during active states, and quiet during 'inactive' states, as shown by the frequency of GCaMP3 transients during these states ( Fig. 3a-d ).
Although we observed some behaviour-related activation when transients were aligned to individual actions (for example, magazine entries or lever presses; Supplementary Fig. 14) , the strongest phasic activation occurred before the initiation of a set of actions or action sequences ( Fig. 3e , f), consistent with previous studies 23 .
To investigate in detail the relationship between these transients and behaviour, we examined fluorescence transients in direct-and indirect-pathway SPNs in relation to the initiation of particular actions. As SPN activity during action generation can depend on the direction and acceleration or speed of the movement, as well as the motivational state of the animal 4,24 , we compared activity during four frequent types of actions in the operant box that were roughly equivalent in acceleration and speed ( Supplementary Fig. 13 ) but had different directions and different motivational goals (initiating a bout of operant presses after magazine entry, or approaching the magazine after a pressing bout, Fig. 4a and Supplementary Video 1). Actions 'left lever to magazine' (LL to M) and 'right lever to magazine' (RL to M) were presumably equal in motivational state but opposite in movement direction. Similarly, action 'magazine to left lever' (M to LL) and 'magazine to right lever' (M to RL) are another pair of actions with similar motivational states but opposite movement directions.
Indirect pathway
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We aligned the GCaMP3 fluorescence signal to the first video frame that showed movement in each action, and observed that both directand indirect-pathway SPNs in the left striatum showed strongest activation during rightward movement (LL to M (Fig. 4b , c, first column) and M to RL (Fig. 4b, c , last column)), irrespective of motivational state. This was not observed for leftward movement, regardless of the motivational states (RL to M and M to LL, (Fig. 4b, c , second and third columns)). However, leftward movements were associated with increased transients in the right striatum ( Supplementary Fig. 13 ). Thus, self-paced movement initiation towards the contralateral side is associated with co-activation of both direct and indirect pathways.
The onset of GCaMP3 fluorescence transients in both pathways preceded movement onset. To test further the relationship between direct-and indirect-pathway SPN activity and the initiation of specific contraversive movement, we aligned the video frames to the onset of the GCaMP3 transients and compared the movement status within a 400-ms window before (2500 ms to 2100 ms) and after (100 ms to 500 ms) the onset of the transients (Fig. 4d, g) . Transients in both direct-and indirect-pathway SPNs of left striatum reliably preceded movement initiation, and predicted the occurrence of a contraversive movement or a complex movement (but not a straight or ipsilateral movement) within 500 ms of the start of the activity transient ( Fig. 4e , f, h, i). Conversely, before a fluorescence transient occurred in both pathways there was a high probability that the animal was inactive (or with less probability, performing an ipsilateral movement) ( Fig. 4e, h) , indicating further that fluorescence transients in both pathways occurred mostly during movement initiation or during transitions, and predicted the occurrence of specific movements.
In summary, we have developed a new in vivo fibre-optic technique for monitoring the activity of specific cell types deep in the brain, and have provided the first definitive evidence that direct-and indirectpathway striatal neurons are co-activated during movement initiation, and are inactive when the animal is not moving. These data call into question the predominant current model of basal ganglia function, which postulates that there should be more activity in the direct pathway during movement than during immobility, and more activity in the indirect pathway during immobility than during movement. We also observed that neuronal activation in both pathways preceded movement initiation (with a latency appropriate for movement control). Finally, we showed that activity in both pathways predicted the occurrence of specific movements within 500 ms of transient initiation. Although these data do not support a pro-kinetic versus antikinetic dichotomy in direct and indirect pathways, they are consistent with other models that propose that the coordinated activation of both pathways is important for action selection, or for the precise timing of basal ganglia output 12, 13, 25 .
Our data on indirect-pathway SPNs may seem to be at odds with recent studies showing that optical activation of indirect-pathway SPNs decreases locomotion 26 , and that ablating 27 or disrupting the function 28 of indirect-pathway SPNs increases locomotion. However, these optogenetic and lesion findings are not inconsistent with models postulating that co-activation of both pathways are important for action selection, with direct-pathway neurons promoting the wanted motor program and indirect-pathway neurons inhibiting competing motor programs. According to these models, during normal behaviour the coordinated activation of particular groups of direct and indirectpathway SPNs would promote selection and initiation of a particular movement. In contrast, non-selective global activation of an entire population of indirect-pathway SPNs 26 would probably inhibit most motor programs and not only unwanted ones, leading to bradykinesia. Conversely, inhibiting or ablating most indirect-pathway SPNs 27, 28 would abolish suppression of unwanted motor programs and induce hyperkinesia. Opposite results could be expected for global directpathway manipulations. Future studies aimed at examining the changes in activity of direct-and indirect-pathway SPNs during basal ganglia disease may shed light on the origin of the motor symptoms associated with basal ganglia dysfunction.
The use of deep brain-inserted fibre optics in freely moving mice enabled us to monitor changes in the fluorescence intensity of a GECI reflecting intracellular calcium transients in specific subgroups of SPNs that control voluntary actions. The spectral and lifetime measurements made using TCSPC provide confirmation of the source of 
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fluorescence transients, which is not possible with simpler intensitybased fluorometry techniques. The same instrumentation (and biosensor expression strategy) could also be used to monitor changes in fluorescence emission spectra and/or fluorescence lifetime. We envision using this methodology with other fluorophores to examine key downstream changes in protein-protein interactions (using fluorescencelifetime imaging microscopy and Förster (fluorescence) resonance energy transfer (FLIM-FRET) 29 ) and metabolism (using spectral FLIM 30 ) that these calcium transients trigger to control behaviour.
METHODS SUMMARY
Experiments were approved by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) Animal Care and Use Committee, and were in accordance with National Institutes of Health (NIH) guidelines. GCaMP3 was expressed in direct-and indirect-pathway SPNs by microinjection of AAV vectors containing FLEX-GCaMP3 into dorsal striatum of D1-Cre and A2A-Cre mice. Operant training began with a two-lever free-choice fixed-ratio 1 schedule (one reward per press), then progressed to fixed-ratio 5, and finally reached fixed-ratio 10.
In vivo optical recording was carried out during the fixed-ratio 10 schedule. The fluorescence signal was acquired at 20 Hz by a 16-channel TCSPC system (Becker & Hickl GmbH). The time stamps of behavioural events automatically detected by the operant chamber (Med-Associates) were fed online into a Plexon MAP system. All behavioural tests were also recorded by a video camera at 30 frames per s for detailed behaviour analysis. Data were analysed offline using Neuroexplorer (Plexon), Matlab, Prism and Image J.
METHODS
Animals. All animal protocols were approved by the US National Institute on Alcohol Abuse and Alcoholism Animal Care and Use Committee. Experiments were carried out using 3-to 12-month-old male and female mice. D1-Cre, A2A-Cre and D2-GFP bacterial artificial chromosome (BAC) transgenic mice were obtained from the Gene Expression Nervous System Atlas (GENSAT; founder line EY217 for D1-Cre and KG139 for A2A-Cre). Floxed-stop GCaMP3 reporter mice (Ai38) were purchased from the Jackson Laboratory and were crossed with A2A-Cre mice for immuno-staining and in vitro slice physiology. Viral Expression of GCaMP3 in direct-and indirect-pathway striatal neurons.
To achieve Cre-dependent expression of GCaMP3 in direct-and indirect-pathway SPNs, AAV vectors containing FLEX-GCaMP3 (AAV2/9.hSynap.Flex.GCaMP3. 3.SV40, made by Penn Vector Core, lot no. V2178, titre 1.26 3 10 13 genome copies per ml) were micro-injected unilaterally into the left or right dorsal striatum by stereotaxic surgery. During the surgery, a small skull window (1 mm 3 1 mm) above the injection site was opened with a dental drill. A 30-gauge injection needle was lowered to the dorsal striatum (tip coordinates from Bregma: anteroposterior 10.5 mm, mediolateral 11.5 mm for left, 21.5 mm for right, dorsoventral 22.5 mm from brain surface). A total volume of 0.8 ml of AAV vector per site was injected in 5-10 min. The needle was left in place for a further 10 min before removal. The skull window was then covered with dental acrylic. Animals were allowed to recover for at least 2 weeks before experiments proceeded. We checked the GCaMP3 signals in vivo at different time points after virus injection. Although the GCaMP3 spectrum started to appear 2 weeks after injection, it was highly contaminated by the background autofluorescence, indicated by the low ratio of peak GCaMP3 to peak autofluorescence ( Supplementary Fig. 4 ). The peak GCaMP3 to peak autofluorescence ratio grew higher over time and stabilized after 2 months ( Supplementary Fig. 4 ). Thus, for in vivo GCaMP3 measurements included in this study, we used animals that received virus injection at least 2 months before the measurements. System design for in vivo measurement of activity-dependent fluorescence changes in behaving mice. The system consists of three interconnected modules: the behaviour and control module (Med-Associates), the Plexon MAP system (Plexon) and the TCSPC-based optical measurement system (Becker & Hickl) (Fig. 1a) . The behaviour and control module controls the outputs (for example, levers and house light) of the operant chamber and feeds the time stamps of the automatically detected behavioural events to the Plexon system. The Plexon system records all the behavioural-event time stamps and can be used for simultaneous electrophysiological recording when needed. The behaviour and control module also sends out commands to synchronize the TCSPC system and the Plexon system, so that the acquired fluorescence signal can be precisely aligned with the recorded behaviour events (temporal shifts 6 10 ms). The optical measurement system is a multi-wavelength TCSPC system that simultaneously records the fluorescence spectrum, intensity and lifetime. Within the optical system, a 473-nm pulsed laser is used to excite the brain tissue at 20 MHz through a polarization-maintaining single-mode fibre (although non-polarizationmaintaining single-mode fibres are also suitable for use as the excitation fibre, we used polarization-maintaining fibres in our system for applications that are not included in this study). Single-mode fibres were specifically used because the 473-nm light output from these fibres forms a stable, near-perfect Gaussian beam profile, which is required for establishing a stable and reproducible excitation volume at the end of the fibre. At 20 MHz the continuous-wave-equivalent power measured at the free end of the single-mode fibre was approximately 0.1-0.12 mW. Photons emitted from the tissue were collected using a multi-mode fibre and dispersed into spectra by a polychromator. The resulting spectra were projected onto a 16-channel PMT array (PML-16C, Becker & Hickl). The individual photons detected in each PMT channel are recorded by a TCSPC module (SPC-830, Becker & Hickl). The 16-channel PMT array covers a 106-nm wavelength window that can be adjusted anywhere 300 nm and 850 nm using a set screw. The shape and location of the spectrum, and the fluorescence lifetime were used to confirm that detected photons were emitted from GCaMP3. The integrated photon count was used as a measure of intensity. Only animals with high GCaMP3 expression (a peak GCaMP3 to peak autofluorescence ratio higher than 5) and signature lifetime (approximately 2.1 ns) ( Fig. 1b-d) were used in behaviour tests and optical measurements. Fabrication of the hybrid optical-fibre probe. A jacketed (outside diameter of 0.9-mm) polarization-maintaining fibre patch cord (core/cladding Ø 3.5/125 mm, OZ Optics) and a jacketed (outside diameter of 0.9-mm) multi-mode fibre patch cord (core/cladding Ø 105/125 mm, Thorlabs) were used for fluorescence excitation and detection, respectively. To make the hybrid probe, a jacket (approximately 15 mm long) and acrylic buffer were stripped off at the free ends of the two fibres to expose the cladding. Then fibre ends (approximately 5 mm long) were cleaved off with a fibre cleaver, leaving 10-mm flat-cleaved naked fibre ends.
Under a dissection microscope, the two exposed fibre ends were placed parallel to each other and pressed tightly together. Small adjustments were made to align the tips so that the two fibres stopped at the same plane without staggering. A thin layer of acrylic glue was applied to the fibre ends 5 mm away from the tips. The bound fibre ends then went through a 5-mm long 19-or 20-gauge protective metal tube until the metal tube met with the fibre jackets, leaving 5-mm long naked fibre ends protruding from the other end of the metal tube. More acrylic glue was applied to both ends of the metal tube to ensure a tight bond between the jackets, fibres and the metal tube ( Supplementary Fig. 2a, b) .
Effects of Ca 21 concentration on GCaMP3 fluorescence intensity and lifetime in vitro. Striata from an AAV FLEX-GCaMP3-injected A2A-Cre mouse and a non-injected A2A-Cre mouse (a wild-type control) were dissected and sonicated in two 1.5-ml Eppendorf tubes filled with 1.0 ml patch pipette internal solution (containing in mM: 135 KMeSO 4 , 4 MgCl 2 , 10 HEPES, 0.4 GTP-sodium salt, 4 ATP-Na 2 , 10 phosphocreatine disodium salt, pH 7.2) and 1:100 diluted protease inhibitor cocktail (Sigma-Aldrich), then centrifuged at 13,000 r.p.m. for 10 min. Supernatant (500 ml) from each tube was transferred into new 1.5-ml tubes and kept on ice before measurement. During the measurement, a hybrid fibre probe (see description above) was attached to the vertical arm of a mouse stereotaxic (David Kopf Instruments) and lowered into the supernatant (approximately 1 mm below surface). Each sample was measured with increasing exogenous Ca 21 concentrations (0, 1, 10 and 100 mM). The Ca 21 concentration was increased by adding 1 ml of 0.5, 5 and 50 mM CaCl 2 stock solution into the 500-ml supernatant. Five measurements were taken for each Ca 21 concentration. Fluorescence intensity was calculated as the total photon count from eight peak spectral channels (channels 6-13, corresponding approximately to 497-543 nm) integrated over 10 s during each measurement. Fluorescence lifetime constant t was calculated by fitting the fluorescence decay curve with a single exponential decay equation.
Measuring the approximate excitation and detection depth in the mouse brain tissue using the hybrid fibre probe. The theoretical excitation and detection volume using two parallel fibres is the overlapping volume of the two acceptance cones formed at the free fibre ends. For the multi-mode detection fibre, the acceptance angle h max can be calculated from the numerical aperture of the fibre and the refractive index n of the sample using the equation n?sinh max 5 numerical aperture. Since the average refractive index of brain tissue is between 1.35 and 1.37 (refs 31, 32) , the numerical aperture of the multi-mode fibre used in this study is 0.22, the full acceptance angle h max of the detection fibre is estimated to be around 19 degrees. As the acceptance angle of the polarization-maintaining excitation fibre cannot be accurately deduced from its numerical aperture number, and because the brain tissue causes strong light scattering, we designed two experiments to estimate empirically the actual excitation and detection depth using fluorescent brain tissue. In the first experiment, we sacrificed a D2-GFP mouse and excised the brain, glued the brain on a plate and sliced it using a vibratome until a coronal section containing the striatum was seen clearly. Then the brain was transferred to a dish containing artificial cerebrospinal fluid (aCSF; see below for formula) under a fluorescence microscope. The hybrid fibre probe was inserted through the cortex and stopped in the dorsal striatum. The striatum was illuminated by the laser beam coming out of the probe and pictures showing GFP fluorescence were taken using a cooled charge-coupled device (CCD) camera (DP71, Olympus, Japan). The approximate volume of fluorophore that can be excited by the polarization-maintaining fibre was estimated using these images ( Supplementary Fig. 2c ). In the second experiment, we measured the maximum depth of detection of our TCSPC system using a method shown in Supplementary  Fig. 2d-f . The rationale for this experiment is that when the fibre probe is moving down vertically through a block of brain tissue with homogenously distributed fluorophores, the detected photon numbers should be constant until the 'bottom' of the detection cone reaches the bottom surface of the brain block. Proceeding beyond this depth will reduce the total number of fluorophores residing within the detection cone and result in a decrease of the detected photon numbers. The detection depth of the probe was estimated as the distance between two planes: the plane at which the photon counts start to decrease and the plane at which the photon counts are close to zero. Results from these two experiments suggest that in the fluorescent brain tissue, the detection volume had a depth of approximately 500 mm. Thus, a feature of the technique used here is that it reflects the average activity of specific neural populations, and hence, activation of a small number of neurons during particular behaviours may not be detected easily compared to the coordinated activity of large numbers of neurons. Therefore, this technique may be more suitable to test specific predictions of whole-circuit behaviour than to examine the detailed behaviour of small subpopulations of neurons within a particular cell type. This feature would predict that if only a small percentage of indirect-pathway SPNs are active during movement initiation we would not be able to detect them,
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and if a large proportion of neurons are active when the animal is not moving we would detect them (and the reverse for the direct-pathway SPNs). Two-lever free-choice operant behaviour training. Behaviour training and optical measurements were carried out in an open-top mouse operant chamber (21.6 3 17.8 3 12.7 cm, Med-Associates) housed in a custom-made sound attenuating box. A recessed food magazine flanked by two retractable levers was located close to the bottom of a chamber wall. A 3-W house light was mounted on the wall opposite to the food magazine. Food was restricted throughout the training and mice were maintained at 85% of their original body weight by adjusting the amount of regular laboratory chow given at the end of each day. The training started with a two-lever free-choice fixed-ratio 1 schedule, in which the animals obtained one food reward (20 mg purified pellets from Bio-Serv) after each left-or right-lever press. Each fixed-ratio 1 session lasted 90 min or until mice received 30 rewards. Once the animals were able to obtain 30 rewards within 90 min, the training progressed to a two-lever free-choice fixed-ratio 5 schedule, in which a total of 5 lever presses, regardless of left or right, were needed for each reward delivery. The training moved on to two-lever free-choice fixed-ratio 10 schedule after the animals could obtain 30 rewards in 90 min in ratio 5 sessions. The animals were then trained in fixed-ratio 10 sessions until they could obtain 30 rewards in 30 min. On average, it took 5 to 7 days of training, 1 to 2 sessions per day, for animals to be ready for optical measurement. Some of the animals trained in the two-lever free-choice task developed strong bias towards one of the two levers during the training, making it difficult to obtain within-subject comparison of left-lever and right-lever pressing behaviours. In these cases, we further trained the animals in pairs of single-lever FR10 sessions during which either the left or right lever was presented. For each trained animal, the optical measurements were carried out in two consecutive sessions with either left or right lever presented. To minimize the impact of satiety levels between sessions, only 10 rewards were obtained by the animal in each session. Procedures to lower the fibre probe into the dorsal striatum for in vivo optical measurement. On the day of optical measurement, brief surgery was carried out to lower the optical fibre probe into the dorsal striatum while the animal was under isoflurane anaesthesia. The dental acrylic covering the previously drilled skull window was carefully removed with a dental drill until the window was fully exposed. The hybrid optical-fibre probe was slowly lowered into the cortex along the lateral edge of the skull window towards the dorsal striatum at approximately 200 mm per step until the GCaMP3 spectrum was detected. The probe was then lowered at 50 mm per step until the fluorescence intensity reached a plateau. The final tip location was anteroposterior 10.5 mm, mediolateral 12.0 mm (left), 22.0 mm (right) from Bregma, approximately 2 mm below the brain surface. The probe was then fixed in place with a generous quantity of dental acrylic to ensure a sturdy bond between the probe and the skull. The optical-fibre-tethered animal was transferred to the operant chamber and recovered for 2 h under supervision. In vivo optical measurement in mice performing operant tasks. The recording session began with a session-start signal, house lights being turned on, and both left and right levers being extended into the chamber. The spectrum data were recorded continuously at 20 Hz for 1 min then paused for 5 s for system buffering. The 1-min acquisition and 5-s buffering were repeated 30 times during the operant session or until the system received a session-end signal from the behaviour recording and control module (if the animal obtained 30 rewards within 30 min). The percentage DF/F was calculated by 100 3 (F 2 F mean )/F mean , where F mean was the mean fluorescence intensity throughout an entire 1-min acquisition fragment. Fluorescence intensity was calculated as the total photon count from 8 peak spectral channels integrated over 50 ms. Spectral channels 6-13 (approximately 497-543 nm) and 5-12 (approximately 490-537 nm) were selected for GCaMP3 and GFP, repectively, owing to the slight red shift of the GCaMP3 emission spectrum relative to GFP (Fig. 1c) . The detection threshold for a fluorescence transient (Figs 3c, d and 4d -i) was defined as m 1 3s, where m and s were the mean and the standard deviation of the 500-ms fluorescence baseline period preceding the interrogated data point. The 'inactive states' (Fig. 3c, d) , were defined as a 15-s period with no detected operant actions. An action sequence (Fig. 3e, f) was defined as a series of action events (magazine entries and lever presses) with inter-event interval of less than 5 s. In the probability analysis (Fig. 4e, h) , probability was calculated from 30 to 40 fluorescence transients per animal. 'Left turn' and 'right turn' were defined as unidirectional body movements with rotation of the long axis of more than 30 degrees, accompanied by head turning towards the same direction. 'Straight' was defined as body movement with less than a 30-degree change in the direction of the long axis and without head turn. 'Complex' was defined as rapid movements with abrupt shift in left and right direction. Effects of isoflurane anaesthesia on fluorescence signals in the striatum. Optical-fibre-tethered animals were first placed in a novel cage with fresh bedding and baseline activity was recorded for 5 min. They were then transferred into an anaesthesia-induction chamber continuously infused with an isoflurane and O 2 mixture. The O 2 flow rate was set at 1.5-2 l min 21 . The isoflurane vaporizer (E-Z Anaesthesia, E-Z Systems Corp) setting was initially set at 5, then adjusted to between 5 and 1 to maintain deep anaesthesia in the animals. After recording for 5 min in the chamber, the animals were placed back in the novel cage and recorded for a further 20 min during recovery. Effects of isoflurane anaesthesia on striatal local-field potentials. The isoflurane anaesthesia procedures were the same as in the previous paragraph. Microwire electrode arrays used for recording striatal local-field potentials and single units consisted of two rows of eight polyamide-coated tungsten microwires with platinum-plated tips (35 mm diameter, CD Neural Technologies). The two rows were separated by 200 mm. The inter-electrode spacing within each row was 150 mm. The procedures for implanting microwire electrode arrays and recording in behaving animals have been described previously 33 . During the surgery, the centre of the array was placed at 0.5 mm rostral to the bregma, 1.5 mm left to the bregma. The array was lowered through a 1 mm 3 2 mm skull window and inserted 2.5 mm below the brain surface, then fixed in place with dental acrylic. Animals were allowed to recover for at least 2 weeks before experiments started. Local-field potentials were recorded using the MAP system (Plexon) and analysed using Neuroexplorer (Plexon) 3 . Simultaneous GCaMP3 Ca 21 imaging and cell-attached firing recording in acutely cut brain slices. Coronal slices (250-mm thick) containing the striatum from 1-to 2-month-old A2A-Cre; floxed-stop GCaMP3 double-mutant mice were cut using a vibratome (Leica VT1200) in cold sucrose cutting solution containing (in mM): 194 sucrose, 30 NaCl, 4.5 KCl, 1 MgCl 2 , 26 NaHCO 3 , 1.2 NaH 2 PO 4 , 10 glucose and incubated at 35 uC for 30 min in aCSF containing the following (in mM): 124 NaCl, 4.5 KCl, 1.2 NaH 2 PO 4 , 1 MgCl 2 , 2 CaCl 2 , 10 glucose, 26 NaHCO 3 , saturated with 95% O 2 and 5% CO 2 (final pH, 7.4; osmolarity, 310 mOsm kg 21 ). The slices were then transferred to room temperature (approximately 24 uC) before recording. All recordings were carried out at room temperature. A Neo sCMOS camera (Andor Technology) installed on a SliceScope (Scientifica) upright microscope was used for imaging. The slices were visualized with a water-immersion objective (340, numerical aperture of 0.8) using either differential interference contrast (DIC) optics or fluorescence excitation with a mercury lamp and GFP filters. Andor SOLIS software was used to capture and analyse the images. To find healthy GCaMP3-expressing cells that were responsive to synaptic activation, a brief train (5 pulses at 100 Hz) of stimulating pulses (0.2 ms, 500 mA) was applied through a concentric bipolar electrode (inner pole diameter of 25 mm, CBARC75 from FHC) before attempting patch-clamp recordings. Many cells that exhibited no detectable fluorescence under resting conditions showed fluorescence transients during and after stimulation. The location of these cells was marked and patch-clamp recordings were established on them under DIC optics. All electrophysiological recordings and current injections were carried out in tight-seal (.2-GV) cell-attached mode 34 using a Multiclamp 700A amplifier (Molecular Devices). Data were acquired using Clampex 8.0 (Molecular Devices), filtered at 5 kHz and digitized at 10 kHz. The patch-pipette solution contained (in mM): 126 K-Gluconate, 4 KCl, 10 HEPES, 4 ATP-Mg, 0.3 GTP-Na, 10 Phosphocreatine (pH 7.2, 290 Osm kg 21 ). To measure synaptic stimulation-evoked GCaMP3 fluorescence transients using the TCSPCbased fibre-optics system, the hybrid fibre probe (see descriptions above) was positioned on the stage with the tip touching the surface of the slice at an approximately 45-degree angle. The stimulating electrode was placed approximately 50-100 mm away from the tip of the fibre probe. The time-resolved spectra were recorded at 20 Hz. Double immunostaining. Brains of AAV FLEX-GCaMP3-injected A2A-Cre mice and A2A-Cre;FLEX-GCaMP3 double-mutant reporter mice were first fixed by transcardial perfusion of 4% PFA, then stored in 4% PFA at 4 uC overnight. Coronal slices (30 mm) were cut using a microtome (VIBRATOME 1000 Plus) and blocked with 4% horse serum before being incubated in primary antibodies at 4 uC overnight. The primary antibodies used were: chicken anti-GFP (1:1000, Abchem) for detecting GCaMP3, rabbit anti-ChAT (1:1000, Millipore) for detecting ChAT; rabbit anti-Met-ENK (1:1000, Millipore) for detecting Met-ENK; and rabbit anti-TH (1:1000, Millipore) for detecting tyrosine hydroxylase. After washing out excessive primary antibodies, the slices were incubated in the secondary antibodies for 2 h at room temperature. The secondary antibodies used were Alexa488 conjugated goat anti-chicken (1:1000, Invitrogen) and Alexa568 conjugated goat anti-rabbit (1:1000, Invitrogen). Cells were visualized using a Zeiss Axiocam MR monochrome camera installed on Axiovert 200 fluorescent microscope with a 310 (numerical aperture 0.3) or a 320 (numerical aperture 0.8) objective. Images were acquired using Axiovision 4.8 software (Zeiss). Imaging acute brain slices for verification of GCaMP3 expression and location of the fibre-probe tip. Sagittal slices (300-mm thick) containing the striatum from RESEARCH LETTER
